Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Escribano

Showing results (91-100 of 270) with videos related to

Pageof 27
Sort By:
Applied Health Economics and Health Policy|March 29, 2012
Cost effectiveness of prostacyclins in pulmonary arterial hypertensionAntonio Roman, Joan A Barberà, Pilar Escribano, et al.
Infectious Diseases and Therapy|February 7, 2020
Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?Antonio Vena, Patricia Muñoz, Miriam Mateos, et al.
Journal of Personalized Medicine|October 27, 2022
Preoperative Prediction of Catheter Ablation Outcome in Persistent Atrial Fibrillation Patients through Spectral Organization Analysis of the Surface Fibrillatory WavesPilar Escribano, Juan Ródenas, Manuel García, et al.
Advances in Therapy|July 31, 2024
Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study)Tobias J Lange, Pilar Escribano-Subias, Audrey Muller, et al.
Pulmonary Circulation|July 30, 2024
Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD): Real-world experience from EXPOSURESean Gaine, Pilar Escribano-Subias, Audrey Muller, et al.
Frontiers in Microbiology|January 27, 2023
Determination of the ability of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify high-biofilm-producing strainsDavid Rodríguez-Temporal, Rafael Díez, Marta Díaz-Navarro, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2018
Resistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture SamplesMaría Ángeles Bordallo-Cardona, Laura Judith Marcos-Zambrano, Carlos Sánchez-Carrillo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 19, 2022
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in SpainEva Alcoceba, Ana Gómez, Paula Lara-Esbrí, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2018
<i>MSH2</i> Gene Point Mutations Are Not Antifungal Resistance Markers in <i>Candida glabrata</i>María Ángeles Bordallo-Cardona, Caroline Agnelli, Ana Gómez-Nuñez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 14, 2006
Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experienceMaria Jose Ruiz, Pilar Escribano, Juan F Delgado, et al.
Pageof 27

Showing results (91-100 of 270) with videos related to

Sort By:
Pageof 27
Applied Health Economics and Health Policy|March 29, 2012
Cost effectiveness of prostacyclins in pulmonary arterial hypertensionAntonio Roman, Joan A Barberà, Pilar Escribano, et al.
Infectious Diseases and Therapy|February 7, 2020
Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?Antonio Vena, Patricia Muñoz, Miriam Mateos, et al.
Journal of Personalized Medicine|October 27, 2022
Preoperative Prediction of Catheter Ablation Outcome in Persistent Atrial Fibrillation Patients through Spectral Organization Analysis of the Surface Fibrillatory WavesPilar Escribano, Juan Ródenas, Manuel García, et al.
Advances in Therapy|July 31, 2024
Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study)Tobias J Lange, Pilar Escribano-Subias, Audrey Muller, et al.
Pulmonary Circulation|July 30, 2024
Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD): Real-world experience from EXPOSURESean Gaine, Pilar Escribano-Subias, Audrey Muller, et al.
Frontiers in Microbiology|January 27, 2023
Determination of the ability of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify high-biofilm-producing strainsDavid Rodríguez-Temporal, Rafael Díez, Marta Díaz-Navarro, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2018
Resistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture SamplesMaría Ángeles Bordallo-Cardona, Laura Judith Marcos-Zambrano, Carlos Sánchez-Carrillo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 19, 2022
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in SpainEva Alcoceba, Ana Gómez, Paula Lara-Esbrí, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2018
<i>MSH2</i> Gene Point Mutations Are Not Antifungal Resistance Markers in <i>Candida glabrata</i>María Ángeles Bordallo-Cardona, Caroline Agnelli, Ana Gómez-Nuñez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 14, 2006
Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experienceMaria Jose Ruiz, Pilar Escribano, Juan F Delgado, et al.
Pageof 27